NICE and easy? Ensuring equitable access to NICE-approved treatments in children and young people

Turner, Paul J, Makwana, Nick, Roberts, Graham and Fox, Adam T (2022) NICE and easy? Ensuring equitable access to NICE-approved treatments in children and young people. Archives of Disease in Childhood, 107 (9), 778-779, [archdischild-2022-324139]. (doi:10.1136/archdischild-2022-324139).

Record type: Editorial

Abstract

The National Institute for Health and Care Excellence (NICE) recently approved Palforzia, an oral immunotherapy product for the treatment of peanut allergy in peanut-allergic children aged 4–17 years.1 Palforzia contains precise amounts of defatted peanut powder and can be used to gradually increase the body’s ability to tolerate small amounts of peanut. It may also help reduce the severity of allergic reactions after being exposed to peanut

Text

ADC NICE PALFORZIA editorial POST RV clean - Author's Original

Available under License Creative Commons Attribution Non-commercial.

Download (25kB)

More information

e-pub ahead of print date: 22 April 2022

Published date: 1 September 2022

Additional Information: Funding Information: Aimmune Therapeutics, DBV Technologies, Allergenis, Aquestive, UK Food Standards Agency and ILSI Europe; grants from National Institute for Health Research (NIHR)/Imperial Biomedical Research Centre, UK Medical Research Council, UK Food Standards Agency, End Allergies Together, Jon Moulton Charity Trust, outside the submitted work. NM is current Chairperson of the BSACI Paediatric Allergy Committee and reports advisory board fees from Aimmune Therapeutics and DBV Technologies. GR is current President of the BSACI and reports grants from UK Food Standards Agency, DBV and the European Union, and funding from the Natasha Allergy Research Foundation. ATF is a trustee and past-president of the BSACI and reports consultancy for Aimmune Therapeutics on behalf of GST consulting (no personal fee) and has been a subinvestigator on Aimmune trials. He is the director of Food Allergy Immunotherapy and chair of the Health Advisory Board of Allergy UK.

Keywords: Allergy and Immunology, Child Health, Health Care Economics and Organizations

Learn more about Institute for Life Sciences research